Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yitian Wang, Li Min, Yong Zhou, Yi Luo, Hong Duan & Chongqi Tu. (2018) The efficacy and safety of apatinib in Ewing’s sarcoma: a retrospective analysis in one institution. Cancer Management and Research 10, pages 6835-6842.
Read now
Read now
Articles from other publishers (8)
Sukanya Chakraborty, Aaqib M. Bhat, Insha Mushtaq, Haitao Luan, Achyuth Kalluchi, Sameer Mirza, Matthew D. Storck, Nagendra Chaturvedi, Jose Antonio Lopez-Guerrero, Antonio Llombart-Bosch, Isidro Machado, Katia Scotlandi, Jane L. Meza, Gargi Ghosal, Donald W. Coulter, M. Jordan Rowley, Vimla Band, Bhopal C. Mohapatra & Hamid Band. (2023) EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis. Communications Biology 6:1.
Crossref
Crossref
Shenglong Li, Fei Liu, Ke Zheng, Wei Wang, Enduo Qiu, Yi Pei, Shuang Wang, Jiaming Zhang & Xiaojing Zhang. (2021) CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis. Molecular Cancer 20:1.
Crossref
Crossref
Sophie L. Kerschner-Morales, Marie Kühne, Sabine Becker, James F. Beck & Jürgen Sonnemann. (2020) Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells. Journal of Cancer Research and Clinical Oncology 146:11, pages 2871-2883.
Crossref
Crossref
P. Gargallo, A. Juan, Y. Yáñez, S. Dolz, V. Segura, V. Castel & A. Cañete. (2020) Precision medicine in Ewing sarcoma: a translational point of view. Clinical and Translational Oncology 22:9, pages 1440-1454.
Crossref
Crossref
Antoine Italiano, Olivier Mir, Simone Mathoulin-Pelissier, Nicolas Penel, Sophie Piperno-Neumann, Emmanuelle Bompas, Christine Chevreau, Florence Duffaud, Natacha Entz-Werlé, Esma Saada, Isabelle Ray-Coquard, Cyril Lervat, Nathalie Gaspar, Perrine Marec-Berard, Hélène Pacquement, John Wright, Maud Toulmonde, Alban Bessede, Amandine Crombe, Michèle Kind, Carine Bellera & Jean-Yves Blay. (2020) Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial. The Lancet Oncology 21:3, pages 446-455.
Crossref
Crossref
Xianglu Ji, Liping Shan, Peng Shen & Ming He. (2020) Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression. Cell Death & Disease 11:1.
Crossref
Crossref
Sabine Heitzeneder, Elena Sotillo, Jack F Shern, Sivasish Sindiri, Peng Xu, Robert Jones, Michael Pollak, Pernille R Noer, Julie Lorette, Ladan Fazli, Anya Alag, Paul Meltzer, Ching Lau, Cheryl A Conover, Claus Oxvig, Poul H Sorensen, John M Maris, Javed Khan & Crystal L Mackall. (2019) Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion. JNCI: Journal of the National Cancer Institute 111:9, pages 970-982.
Crossref
Crossref
Christine M. Heske, Mindy I. Davis, Joshua T. Baumgart, Kelli Wilson, Michael V. Gormally, Lu Chen, Xiaohu Zhang, Michele Ceribelli, Damien Y. Duveau, Rajarshi Guha, Marc Ferrer, Fernanda I. Arnaldez, Jiuping Ji, Huong-Lan Tran, Yiping Zhang, Arnulfo Mendoza, Lee J. Helman & Craig J. Thomas. (2017) Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. Clinical Cancer Research 23:23, pages 7301-7311.
Crossref
Crossref